HistoIndex Charts New Course in Liver Disease Innovation: Announces Pivotal Changes to Scientific Advisory Board

HistoIndex Singapore

Company to appoint Prof. Arun J. Sanyal as the new Chairman of HistoIndex's Scientific Advisory Board, bringing unparalleled expertise to guide future innovations.Prof. Vlad Ratziu joins the Scientific Advisory Board to strengthen the Company's global scientific leadership in liver disease management.HistoIndex's AI-driven solutions qFibrosis, qSteatosis, and qBallooning can standardize assessments in MASH clinical trials, improving drug efficacy evaluations and patient screening processes.is a pioneer in stain-free, fully automated imaging solutions for visualizing and quantifying fibrosis in tissue biopsies. By combining cutting-edge biophotonic technology with AI-based analysis, HistoIndex provides innovative tools that transform research, expedite pharmaceutical drug development, and set new medical standards.

Photo - https://mma.prnewswire.com/media/2450751/SAB_Press_release.jpg

View original content:https://www.prnewswire.co.uk/news-releases/histoindex-charts-new-course-in-liver-disease-innovation-announces-pivotal-changes-to-scientific-advisory-board-302185815.html